Literature DB >> 12083020

The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer. Bethesda, Maryland, USA. November 1-3, 2000. Proceedings.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 12083020

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN： 1052-6773


× No keyword cloud information.
  6 in total

1.  The International Core Literature Consensus (ICLC): an alternative curriculum for Oncologists.

Authors:  Shilpen Patel; Reshma Jagsi; Natalie Cook; Luke Hughes-Davies; Christine Parkinson
Journal:  J Cancer Educ       Date:  2011-09       Impact factor: 2.037

2.  Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy.

Authors:  Shirin Muhsen; Tracy-Ann Moo; Sujata Patil; Michelle Stempel; Simon Powell; Monica Morrow; Mahmoud El-Tamer
Journal:  Ann Surg Oncol       Date:  2018-03-21       Impact factor: 5.344

Review 3.  Managing high-risk breast cancer.

Authors:  Frances M Palmieri; Edith A Perez
Journal:  Semin Oncol Nurs       Date:  2007-02       Impact factor: 2.315

Review 4.  Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?

Authors:  Edith D Canby-Hagino; Gregory P Swanson; E David Crawford; Joseph W Basler; Javier Hernandez; Ian M Thompson
Journal:  Curr Urol Rep       Date:  2005-05       Impact factor: 2.862

Review 5.  Adjuvant systemic therapy of early stage breast cancer.

Authors:  William J Gradishar
Journal:  Curr Treat Options Oncol       Date:  2003-04

6.  Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.

Authors:  Joachim Diessner; Manfred Wischnewsky; Maria Blettner; Sebastian Häusler; Wolfgang Janni; Rolf Kreienberg; Roland Stein; Tanja Stüber; Lukas Schwentner; Catharina Bartmann; Achim Wöckel
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.